Resmed (RMD) announced a comprehensive brand evolution designed to unify its brand portfolio to serve more people and healthcare providers ...

ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

On Monday, Protagonist Therapeutics, Inc. (NASDAQ:PTGX) and Takeda Pharmaceutical Co Ltd (NYSE:TAK) released topline results for the Phase 3 VERIFY study of rusfertide for polycythemia vera.

January 30, 2025 Drugmaker Takeda's CEO Weber to step down, raises profit forecast Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Three years after it was formed as a spinout of Japanese drugmaker Takeda, Phathom Pharmaceuticals has racked up its first FDA approvals, and claimed a sizeable $260 million in new financing to ...

TAK-721 is one of 12 "Wave1" pipeline drug candidates that have been held up by Takeda as potential blockbuster products, because they are either best-in-class or first-in-class therapies. The ...

Plant evolution is the subset of evolutionary phenomena that concern plants. The study of plant evolution includes the study of genetic change and the variations that result in speciation.

Visit a quote page and your recently viewed tickers will be displayed here.